We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. markets closed

CV Sciences, Inc. (CVSI)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0380+0.0035 (+10.14%)
At close: 03:52PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0345
Open0.0345
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0339 - 0.0390
52 Week Range0.0300 - 0.0600
Volume291,225
Avg. Volume248,162
Market Cap6.203M
Beta (5Y Monthly)0.63
PE Ratio (TTM)1.90
EPS (TTM)0.0200
Earnings DateMay 13, 2024 - May 17, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CVSI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CV SCIENCES INC
    Analyst Report: Gap, Inc.Gap Inc. is a specialty retailer of clothing, accessories and personal care products for adults, teens and children. The San Francisco-based company has four brands: Gap, Banana Republic, Athleta, and Old Navy. Gap Inc. operates approximately 2,500 stores and over 900 franchise locations in more than 40 countries. GPS has about 85,000 full-time employees.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • Insider Monkey

    CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript

    CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript March 28, 2024 CV Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to CV Sciences’ Fourth Quarter and Year-End 2023 Conference. At this time, all participants are […]

  • PR Newswire

    CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

    CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2023.

  • PR Newswire

    CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews

    CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, proudly announces its latest innovation and product launch: a premier CBD chew tailored for pets, +PlusCBD™ Pet Hip and Joint Health Chews and +PlusCBD™ Pet Calming Care Chews. +PlusCBD™Pet wellness treats are crafted with the utmost care and supported by extensive research, and

  • PR Newswire

    CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024

    CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in nutraceuticals and plant-based foods, today announced that it will release financial results for the year and fourth quarter ended December 31, 2023, before the stock market opens on Thursday, March 28, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) that same day.

  • PR Newswire

    CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution

    CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has consummated its purchase of Cultured Foods, a leading manufacturer and distributor of alternative plant-based vegan foods. Cultured Foods produces a variety of curated plant-based products, currently sold in 15 different European countries, with its ba

  • Insider Monkey

    CV Sciences, Inc. (PNK:CVSI) Q3 2023 Earnings Call Transcript

    CV Sciences, Inc. (PNK:CVSI) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good day, and welcome to the CV Sciences, Inc. Third Quarter 2023 Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to CV Sciences. Please go ahead. Brendan Hawkins: Thank you, […]

  • PR Newswire

    CV Sciences, Inc. Reports Third Quarter 2023 Financial Results

    CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2023.

  • PR Newswire

    CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023

    CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the third quarter ended September 30, 2023, before the stock market opens on Tuesday, November 14, 2023. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern

  • PR Newswire

    CV Sciences, Inc. Launches Reserve Sleep Gummies

    CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced the launch of +PlusCBD™Reserve Collection Sleep Gummies as the brand continues to expand into the sleep aid market.

  • Insider Monkey

    CV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call Transcript

    CV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call Transcript August 14, 2023 Operator: Hello, and welcome to the CV Sciences, Inc. Second Quarter 2023 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to your host, Brendan Hawkins. Please go ahead. Brendan Hawkins: […]